MedTrace Logo

Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency

NCT00006061 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2005-06-24

No results posted yet for this study

Summary

OBJECTIVES: I. Determine whether plasma choline and breast milk choline levels are low at fasting in a patient with methionine adenosyltransferase deficiency, and if the choline levels are low, determine whether choline levels respond to dietary supplementation with phosphatidylcholine.

II. Determine whether this patient has a fatty liver by magnetic resonance spectroscopy.

Conditions

  • Methionine Adenosyltransferase Deficiency
  • Metabolism, Inborn Errors

Interventions

DRUG

phosphatidylcholine

Sponsors & Collaborators

  • UNC Lineberger Comprehensive Cancer Center

    collaborator OTHER

  • National Center for Research Resources (NCRR)

    lead NIH

Principal Investigators

  • Steven H. Zeisel · UNC Lineberger Comprehensive Cancer Center

Study Design

Purpose
TREATMENT

Eligibility

Min Age
20 Years
Max Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Completion
2000-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00006061 on ClinicalTrials.gov